BRIEF published on 05/21/2025 at 08:05, 1 year 3 months ago TME Pharma Enhances Financial Outlook with €1.7M Bond Commitments Strategic Partnerships Bond Issuance Clinical Programs Financial Visibility Cost Structure
PRESS RELEASE published on 05/21/2025 at 08:00, 1 year 3 months ago Inside Information / Other news releases TME Pharma extends financial visibility to May 2026 by securing €1.7M financing through regular bonds with attached warrants. CEO and board show strong commitment to company's success Clinical Programs TME Pharma Financial Visibility Regular Bonds Private Warrants
BRIEF published on 04/10/2025 at 19:05, 1 year 4 months ago TME Pharma strengthens its liquidity contract with Invest Securities Liquidity Contract Oncology INVEST SECURITIES Financial Markets TME Pharma
PRESS RELEASE published on 04/10/2025 at 19:00, 1 year 4 months ago Inside Information / Other news releases TME Pharma increases resources for liquidity contract with Invest Securities by €5,000 to support cash balance and securities. Details of shares and cash balance provided Liquidity Contract INVEST SECURITIES Clinical-stage Biotechnology Resources TME Pharma
BRIEF published on 02/17/2025 at 08:05, 1 year 6 months ago TME Pharma Outlines 2025 Strategic Roadmap and Initiatives Strategic Partnerships Biotechnology Drug Discovery Cancer Therapy NOX-A12
PRESS RELEASE published on 02/17/2025 at 08:00, 1 year 6 months ago Inside Information / Other news releases TME Pharma CEO Aram Mangasarian outlines key initiatives and milestones for 2025, including strategic partnerships, NOX-A12 clinical development, AI-driven drug discovery, and financial updates Strategic Partnerships Clinical Development CEO Message TME Pharma 2025 Initiatives
BRIEF published on 01/29/2025 at 08:05, 1 year 7 months ago TME Pharma and aimed analytics: Innovative partnership for drug discovery through AI Biotechnology Artificial Intelligence Partnership Cancer Drugs
PRESS RELEASE published on 01/29/2025 at 08:00, 1 year 7 months ago Inside Information / Other news releases TME Pharma collaborates with aimed analytics for AI-driven drug discovery, strengthening capabilities for strategic transactions. The partnership utilizes AI to accelerate drug development and optimize existing therapies Strategic Partnerships Cancer Treatment TME Pharma AI-driven Drug Discovery Aimed Analytics
BRIEF published on 12/23/2024 at 21:09, 1 year 8 months ago Successful public offering of TME Pharma NV Shareholders Capital Increase Cancer Financial Strategies NOX-A12
BRIEF published on 12/04/2024 at 19:55, 1 year 8 months ago TME Pharma Announces Strategic Update and €2.6 Million Financing Plan Public Offer Corporate Strategy Financing Plan NOX-A12 Development Shareholder Priority
Published on 09/01/2026 at 16:10, 3 hours 20 minutes ago Sparton Signs Definitive Morrison Silver Mine Option and Joint Venture Agreement with Glen Eagle; Appoints Vice President, Corporate Development
Published on 09/01/2026 at 15:40, 3 hours 50 minutes ago Norsemont Provides Choquelimpie Drilling Update
Published on 09/01/2026 at 15:30, 4 hours ago Caldwell Launches Global Financial Institutions Group Practice
Published on 09/01/2026 at 14:31, 4 hours 59 minutes ago First Breach Expands Ammunition Manufacturing Capacity with Installation of New Loading and Inspection Equipment
Published on 09/01/2026 at 14:00, 5 hours 30 minutes ago Horizon Aircraft Advances All-Weather Certification Path with the Start of Ice Protection Technology Testing
Published on 09/01/2026 at 18:01, 1 hour 29 minutes ago Gerresheimer AG: Annual General Meeting Approves the Company's Proposed Resolutions by a Majority Vote
Published on 09/01/2026 at 17:35, 1 hour 54 minutes ago Aurzen Launches EAZZE E1 and E1R at IFA 2026, Bringing Smart Big-Screen Entertainment to Everyday Spaces
Published on 09/01/2026 at 19:00, 30 minutes ago Covivio - Information on total number of voting rights and share capital
Published on 09/01/2026 at 18:18, 1 hour 12 minutes ago TF1 - Monthly disclosure of the total number of shares and voting rights - August 2026
Published on 09/01/2026 at 17:44, 1 hour 45 minutes ago Reporting on share buyback transactions carried out between August 18 and August 28, 2026
Published on 09/01/2026 at 17:39, 1 hour 51 minutes ago Disclosure of transactions in own shares of 31 August, 2026
Published on 08/31/2026 at 17:45, 1 day 1 hour ago Disclosure of transactions in own shares from August 24 to August 28, 2026
